173 related articles for article (PubMed ID: 38365418)
1. Design and selection of drug properties to increase the public health impact of next-generation seasonal malaria chemoprevention: a modelling study.
Braunack-Mayer L; Malinga J; Masserey T; Nekkab N; Sen S; Schellenberg D; Tchouatieu AM; Kelly SL; Penny MA
Lancet Glob Health; 2024 Mar; 12(3):e478-e490. PubMed ID: 38365418
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study.
ACCESS-SMC Partnership
Lancet; 2020 Dec; 396(10265):1829-1840. PubMed ID: 33278936
[TBL] [Abstract][Full Text] [Related]
3. Systematic Review and Meta-Analysis of Seasonal Malaria Chemoprevention.
Thwing J; Williamson J; Cavros I; Gutman JR
Am J Trop Med Hyg; 2024 Jan; 110(1):20-31. PubMed ID: 38081050
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Effect of three years' seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali.
Mahamar A; Sumner KM; Levitt B; Freedman B; Traore A; Barry A; Issiaka D; Dembele AB; Kanoute MB; Attaher O; Diarra BN; Sagara I; Djimde A; Duffy PE; Fried M; Taylor SM; Dicko A
Malar J; 2022 Feb; 21(1):39. PubMed ID: 35135546
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial.
Cissé B; Ba EH; Sokhna C; NDiaye JL; Gomis JF; Dial Y; Pitt C; NDiaye M; Cairns M; Faye E; NDiaye M; Lo A; Tine R; Faye S; Faye B; Sy O; Konate L; Kouevijdin E; Flach C; Faye O; Trape JF; Sutherland C; Fall FB; Thior PM; Faye OK; Greenwood B; Gaye O; Milligan P
PLoS Med; 2016 Nov; 13(11):e1002175. PubMed ID: 27875528
[TBL] [Abstract][Full Text] [Related]
7. Understanding and maximising the community impact of seasonal malaria chemoprevention in Burkina Faso (INDIE-SMC): study protocol for a cluster randomised evaluation trial.
Moreno M; Barry A; Gmeiner M; Yaro JB; Sermé SS; Byrne I; Ramjith J; Ouedraogo A; Soulama I; Grignard L; Soremekun S; Koele S; Ter Heine R; Ouedraogo AZ; Sawadogo J; Sanogo E; Ouedraogo IN; Hien D; Sirima SB; Bradley J; Bousema T; Drakeley C; Tiono AB
BMJ Open; 2024 Mar; 14(3):e081682. PubMed ID: 38479748
[TBL] [Abstract][Full Text] [Related]
8. Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial.
NDiaye JL; Cissé B; Ba EH; Gomis JF; Ndour CT; Molez JF; Fall FB; Sokhna C; Faye B; Kouevijdin E; Niane FK; Cairns M; Trape JF; Rogier C; Gaye O; Greenwood BM; Milligan PJ
PLoS One; 2016; 11(10):e0162563. PubMed ID: 27764102
[TBL] [Abstract][Full Text] [Related]
9. Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South Sudan.
Molina-de la Fuente I; Sagrado Benito MJ; Lasry E; Ousley J; García L; González V; Pasquale HA; Julla A; Uwiragiye P; Abdi AM; Chol BT; Abubakr B; Benito A; Casademont C; Berzosa P; Nanclares C
Malar J; 2023 Nov; 22(1):345. PubMed ID: 37950227
[TBL] [Abstract][Full Text] [Related]
10. Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali.
Diawara F; Steinhardt LC; Mahamar A; Traore T; Kone DT; Diawara H; Kamate B; Kone D; Diallo M; Sadou A; Mihigo J; Sagara I; Djimde AA; Eckert E; Dicko A
Malar J; 2017 Aug; 16(1):325. PubMed ID: 28797263
[TBL] [Abstract][Full Text] [Related]
11. Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.
Tagbor H; Antwi GD; Acheampong PR; Bart Plange C; Chandramohan D; Cairns M
Trop Med Int Health; 2016 Feb; 21(2):224-35. PubMed ID: 26578353
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study.
Beshir KB; Muwanguzi J; Nader J; Mansukhani R; Traore A; Gamougam K; Ceesay S; Bazie T; Kolie F; Lamine MM; Cairns M; Snell P; Scott S; Diallo A; Merle CS; NDiaye JL; Razafindralambo L; Moroso D; Ouedraogo JB; Zongo I; Kessely H; Doumagoum D; Bojang K; Ceesay S; Loua K; Maiga H; Dicko A; Sagara I; Laminou IM; Ogboi SJ; Eloike T; Milligan P; Sutherland CJ
Lancet Infect Dis; 2023 Mar; 23(3):361-370. PubMed ID: 36328000
[TBL] [Abstract][Full Text] [Related]
13. Seasonal Malaria Chemoprevention Drug Levels and Drug Resistance Markers in Children With or Without Malaria in Burkina Faso: A Case-Control Study.
Roh ME; Zongo I; Haro A; Huang L; Somé AF; Yerbanga RS; Conrad MD; Wallender E; Legac J; Aweeka F; Ouédraogo JB; Rosenthal PJ
J Infect Dis; 2023 Oct; 228(7):926-935. PubMed ID: 37221018
[TBL] [Abstract][Full Text] [Related]
14. Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.
Grais RF; Laminou IM; Woi-Messe L; Makarimi R; Bouriema SH; Langendorf C; Amambua-Ngwa A; D'Alessandro U; Guérin PJ; Fandeur T; Sibley CH
Malar J; 2018 Feb; 17(1):98. PubMed ID: 29486766
[TBL] [Abstract][Full Text] [Related]
15. Seasonal vaccination with RTS,S/AS01
Dicko A; Ouedraogo JB; Zongo I; Sagara I; Cairns M; Yerbanga RS; Issiaka D; Zoungrana C; Sidibe Y; Tapily A; Nikièma F; Sompougdou F; Sanogo K; Kaya M; Yalcouye H; Dicko OM; Diarra M; Diarra K; Thera I; Haro A; Sienou AA; Traore S; Mahamar A; Dolo A; Kuepfer I; Snell P; Grant J; Webster J; Milligan P; Lee C; Ockenhouse C; Ofori-Anyinam O; Tinto H; Djimde A; Chandramohan D; Greenwood B
Lancet Infect Dis; 2024 Jan; 24(1):75-86. PubMed ID: 37625434
[TBL] [Abstract][Full Text] [Related]
16. Seasonal use case for the RTS,S/AS01 malaria vaccine: a mathematical modelling study.
Thompson HA; Hogan AB; Walker PGT; Winskill P; Zongo I; Sagara I; Tinto H; Ouedraogo JB; Dicko A; Chandramohan D; Greenwood B; Cairns M; Ghani AC
Lancet Glob Health; 2022 Dec; 10(12):e1782-e1792. PubMed ID: 36400084
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution.
Diawara H; Walker P; Cairns M; Steinhardt LC; Diawara F; Kamate B; Duval L; Sicuri E; Sagara I; Sadou A; Mihigo J; Eckert E; Dicko A; Conteh L
Malar J; 2021 Mar; 20(1):128. PubMed ID: 33663488
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Houndé District, Burkina Faso and Bougouni District, Mali.
Cairns ME; Sagara I; Zongo I; Kuepfer I; Thera I; Nikiema F; Diarra M; Yerbanga SR; Barry A; Tapily A; Coumare S; Milligan P; Tinto H; Ouédraogo JB; Chandramohan D; Greenwood B; Djimde A; Dicko A
PLoS Med; 2020 Aug; 17(8):e1003214. PubMed ID: 32822362
[TBL] [Abstract][Full Text] [Related]
19. Seasonal malaria chemoprevention combined with community case management of malaria in children under 10 years of age, over 5 months, in south-east Senegal: A cluster-randomised trial.
Ndiaye JLA; Ndiaye Y; Ba MS; Faye B; Ndiaye M; Seck A; Tine R; Thior PM; Atwal S; Beshir K; Sutherland C; Gaye O; Milligan P
PLoS Med; 2019 Mar; 16(3):e1002762. PubMed ID: 30865632
[TBL] [Abstract][Full Text] [Related]
20. Effect of seasonal malaria chemoprevention plus azithromycin on Plasmodium falciparum transmission: gametocyte infectivity and mosquito fitness.
Yaméogo KB; Yerbanga RS; Ouattara SB; Yao FA; Lefèvre T; Zongo I; Nikièma F; Compaoré YD; Tinto H; Chandramohan D; Greenwood B; Belem AMG; Cohuet A; Ouédraogo JB
Malar J; 2021 Jul; 20(1):326. PubMed ID: 34315475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
